Intrexon | XON - القيمة السوقية





القيمة السوقية تغيير تاريخ
Agenus USD 1.66B 1.55B 2026-03
Alaunos Therapeutics USD 51M 46M 2026-03
Amgen USD 176.25B 24.32B 2025-12
Anika Therapeutics USD 210M 71M 2026-03
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Heron Therapeutics USD 133M 105M 2026-03
Incyte USD 19.39B 2.83B 2025-12
MacroGenics USD 192M 90M 2026-03
MannKind USD 1.74B 93M 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 240.48B 51.73B 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Veracyte USD 3.33B 627M 2025-12
Xencor USD 1.09B 256M 2025-12